Table 1.
The basic characteristics of the research patients
| General characteristics | oAC group | Placebo group | t/X2 | P value |
|---|---|---|---|---|
| Gender (male/female) | 25/24 | 25/23 | 0.011 | 0.917 |
Age ( ± s) |
57.0 ± 16.7 | 56.8 ± 15.8 | 0.067 | 0.861 |
| Chronic kidney disease causes | ||||
| Chronic glomerulonephritis | 19/49 | 19/48 | 0.007 | 1.000 |
| Diabetic nephropathy | 16/49 | 15/48 | 0.022 | 1.000 |
| Hypertensive kidney damage | 7/49 | 6/48 | 0.067 | 1.000 |
| Drug-induced renal damage | 3/49 | 4/48 | 0.177 | 0.715 |
| Polycystic kidney | 2/49 | 1/48 | 0.323 | 1.000 |
| Other | 2/49 | 2/48 | 0.000 | 1.000 |
| Calcium (mg/dl) | 9.49 ± 0.44 | 9.49 ± 0.38 | − 0.052 | 0.959 |
| Phosphorus (mg/dl) | 3.74 ± 0.46 | 3.90 ± 0.41 | − 1.785 | 0.077 |
| iPTH (mmol/l) | 132.27 ± 45.65 | 133.28 ± 45.65 | − 0.111 | 0.912 |
| FGF-23 (pg/ml) | 243.73 ± 26.45 | 243.44 ± 26.72 | 0.055 | 0.956 |
| CACS | 34.35 ± 26.17 | 35.79 ± 23.94 | − 0.284 | 0.777 |